PFC I-PASS Intervention for Enhanced Healthcare Communication
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial focuses on improving hospital communication, particularly for families who speak languages other than English. It tests the effectiveness of two communication methods, PFC I-PASS (Patient and Family Centered I-PASS) and PFC I-PASS+, against usual hospital care. PFC I-PASS+ incorporates interpreters and trains doctors in cultural sensitivity to make hospital rounds more inclusive. Patients admitted to pediatric units, especially those whose caregivers speak specified languages like Spanish or Mandarin, might be a good fit for this trial. As an unphased trial, this study provides a unique opportunity to enhance hospital communication for diverse families.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
What prior data suggests that the PFC I-PASS and PFC I-PASS+ interventions are safe for improving healthcare communication?
Research has shown that both the PFC I-PASS and PFC I-PASS+ programs are safe and improve patient care. Earlier studies found that the original PFC I-PASS program reduced unwanted medical issues in hospitals by enhancing communication between doctors, nurses, and patients and their families. This improvement led to fewer problems for patients during their hospital stay.
The PFC I-PASS+ program expands on this by including interpreters and training doctors to communicate more effectively with patients who speak different languages. Although detailed safety data for PFC I-PASS+ is not available, the emphasis on better communication and cultural understanding is generally safe and does not involve medical procedures.
Overall, both programs aim to make hospital stays safer and more welcoming for patients and their families. No reports of serious safety issues have been associated with these communication methods.12345Why are researchers excited about this trial?
Researchers are excited about the PFC I-PASS and PFC I-PASS+ interventions because they aim to revolutionize communication in hospitals, especially during family-centered rounds. Unlike typical practices, which can be unstructured and vary greatly depending on the healthcare provider, these interventions offer a structured communication framework that enhances information exchange between doctors, nurses, and families. The PFC I-PASS+ goes a step further by incorporating interpreters and training for cultural humility, addressing language and cultural barriers directly. This approach not only improves understanding but also actively involves families in daily decision-making, potentially leading to better patient outcomes and satisfaction.
What evidence suggests that this trial's interventions could be effective for improving healthcare communication?
Research has shown that the PFC I-PASS program, one of the interventions in this trial, enhances hospital safety and communication. In seven hospitals, it reduced harmful medical errors by 38% and improved the experience for patients and their families. The PFC I-PASS+ program, another intervention in this trial, includes interpreters and trains doctors to be more culturally aware, helping to overcome language barriers and improve communication. Early results suggest that both programs enhance information sharing and involve families more in healthcare decisions. These programs aim to make hospital visits clearer and more inclusive for everyone.12467
Who Is on the Research Team?
Alisa Khan, MD, MPH
Principal Investigator
Boston Children's Hospital/Harvard Medical School
Are You a Good Fit for This Trial?
This trial is for hospital leaders, patients aged 13+, nurses, parents/caregivers who speak one of the study languages, and medical staff at participating pediatric units. It aims to improve communication during rounds with families, especially those facing language barriers.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Intervention Implementation
Implementation of PFC I-PASS+ and PFC I-PASS interventions, including training and communication strategies
Data Collection
Data collection on adverse events, patient/family experience, and communication quality
Follow-up
Participants are monitored for safety and effectiveness after intervention implementation
What Are the Treatments Tested in This Trial?
Interventions
- PFC I-PASS Intervention
- PFC I-PASS+ Intervention
PFC I-PASS Intervention is already approved in United States for the following indications:
- Improving communication in hospital settings
- Reducing adverse events
- Enhancing patient and family experience
Find a Clinic Near You
Who Is Running the Clinical Trial?
Boston Children's Hospital
Lead Sponsor
Patient-Centered Outcomes Research Institute
Collaborator
Pediatric Research in Inpatient Settings
Collaborator